Aligos Therapeutics, Inc. · NASDAQ:ALGS

Aligos Therapeutics, Inc. shareholders

As of Sep 30, 2026, 35 institutions reported holding Aligos Therapeutics, Inc., 46.6% of its shares. Largest: Deep Track Capital, LP, Sio Capital Management, LLC and Parkman Healthcare Partners LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Aligos Therapeutics, Inc.ChangeFiled
Deep Track Capital, LP444K8.2%no changeNov 16, 2026
Sio Capital Management, LLC327K6.0%no changeNov 16, 2026
Parkman Healthcare Partners LLC326K6.0%newNov 16, 2026
Marshall Wace, LLP247K4.5%no changeNov 13, 2026
Vanguard204K3.7%no changeNov 13, 2026
Schonfeld Strategic Advisors LLC182K3.3%newNov 16, 2026
Woodline Partners LP177K3.3%no changeNov 16, 2026
Baker Bros. Advisors LP83,0551.5%no changeNov 16, 2026
Hhlr Advisors, LTD.76,2471.4%no changeNov 16, 2026
D. E. Shaw & Co., Inc.71,5281.3%+5,065Nov 16, 2026

Aligos Therapeutics, Inc. insider trades